Obesity Featured Articles

  1. Clinical Trials Get A Council For AI Oversight 7/14/2025

    AI in clinical trials is moving fast — but without clear standards for ethics, transparency, or oversight. Advarra's new Council for Responsible Use of AI in Clinical Trials aims to change that. Founding members Sanofi, Recursion, and Velocity Clinical Research are stepping up to define what “responsible” really looks like.

  2. Advancing Drug Safety: The Synergy Of Regulatory Affairs And Pharmacovigilance 7/14/2025

    Explore how pharmacovigilance and regulatory affairs teams work together throughout a product's lifecycle to monitor risks and keep vital safety information updated.

  3. CDISC + TMF Europe Interchange 2025: 5 Key Takeaways 7/14/2025

    The CDISC + TMF Europe Interchange showcased critical insights for TMF professionals. Learn about essential collaboration, the impact of AI, and the continued drive for standardization in clinical trials.

  4. How Digital Twins And Hybrid Modelling Optimize Cell Culture Process For Better Production 7/14/2025

    Discover how digital twins are enabling the optimization of cell culture processes for improved, more predictable outcomes in the creation of therapeutic proteins and antibodies.

  5. The New Language Of E6 R3: What Makes The Guidelines So Different? 7/14/2025

    Unpack the significant changes in ICH E6 (R3), nearly a decade after its last update. This revision brings renewed focus to quality by design and digital provenance.

  6. From Protocol To People: Teva's Patient-First Clinical Trials Approach 7/14/2025

    Teva Pharmaceuticals' Head of Global Early Clinical Development Eran Harary, MD, shares how the company approaches drug development by getting patient input early and often.

  7. A Guide To Guidelines: How ICH And Others Help Us Conduct Better Trials 7/11/2025

    Guidelines abound in clinical research. So, how should sponsor companies and partners think about their role in ensuring compliance? Consultant Kamila Novak explores their importance.

  8. Adaptive By Nature: Modern Tools For Modern Trial Designs 7/10/2025

    Adaptive platform trials (APTs) are reshaping clinical research by enabling multiple therapies to be tested simultaneously under a single, flexible protocol.

  9. New EDC Tools Enable Even Faster Self-Serve Study Builds 7/10/2025

    Explore a powerful yet accessible EDC solution that enables faster, more efficient study builds without compromising data integrity or compliance, allowing clinical teams to focus on advancing research outcomes.

  10. Enhancing Readiness For FDA's Expanded Foreign Inspection Program 7/10/2025

    Learn about the FDA’s expanded, unannounced inspection program for foreign manufacturing sites that aims to align oversight of global pharmaceutical and medical device production with domestic GMP standards.